| Year |
Citation |
Score |
| 2024 |
Jones CA, Wang J, Evans JR, Sisk HR, Womack CB, Liu Q, Tansey WP, Weissmiller AM. Super-Enhancer Dysregulation in Rhabdoid Tumor Cells Is Regulated by the SWI/SNF ATPase BRG1. Cancers. 16. PMID 38473277 DOI: 10.3390/cancers16050916 |
0.361 |
|
| 2023 |
Howard GC, Wang J, Rose KL, Patel P, Tsui T, Florian AC, Lorey SL, Grieb BC, Smith BN, Slota MJ, Reynolds EM, Goswami S, Savona MR, Lee T, Fesik SW, ... ... Tansey WP, et al. Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition. Biorxiv : the Preprint Server For Biology. PMID 37546802 DOI: 10.1101/2023.07.26.550648 |
0.37 |
|
| 2023 |
Bumpous LA, Moe KC, Wang J, Carver LA, Williams AG, Romer AS, Scobee JD, Maxwell JN, Jones CA, Chung DH, Tansey WP, Liu Q, Weissmiller AM. WDR5 facilitates recruitment of N-MYC to conserved WDR5 gene targets in neuroblastoma cell lines. Oncogenesis. 12: 32. PMID 37336886 DOI: 10.1038/s41389-023-00477-z |
0.399 |
|
| 2022 |
Jones CA, Tansey WP, Weissmiller AM. Emerging Themes in Mechanisms of Tumorigenesis by SWI/SNF Subunit Mutation. Epigenetics Insights. 15: 25168657221115656. PMID 35911061 DOI: 10.1177/25168657221115656 |
0.319 |
|
| 2022 |
Moe KC, Maxwell JN, Wang J, Jones CA, Csaki GT, Florian AC, Romer AS, Bryant DL, Farone AL, Liu Q, Tansey WP, Weissmiller AM. The SWI/SNF ATPase BRG1 facilitates multiple pro-tumorigenic gene expression programs in SMARCB1-deficient cancer cells. Oncogenesis. 11: 30. PMID 35650187 DOI: 10.1038/s41389-022-00406-6 |
0.409 |
|
| 2022 |
Metz EP, Wilder PJ, Popay TM, Wang J, Liu Q, Kalluchi A, Rowley MJ, Tansey WP, Rizzino A. Elevating SOX2 Downregulates MYC through a SOX2:MYC Signaling Axis and Induces a Slowly Cycling Proliferative State in Human Tumor Cells. Cancers. 14. PMID 35454854 DOI: 10.3390/cancers14081946 |
0.328 |
|
| 2022 |
Florian AC, Woodley CM, Wang J, Grieb BC, Slota MJ, Guerrazzi K, Hsu CY, Matlock BK, Flaherty DK, Lorey SL, Fesik SW, Howard GC, Liu Q, Weissmiller AM, Tansey WP. Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells. Nar Cancer. 4: zcac007. PMID 35252869 DOI: 10.1093/narcan/zcac007 |
0.327 |
|
| 2021 |
Guarnaccia AD, Weissmiller AM, Tansey WP. Gene-specific quantification of nascent transcription following targeted degradation of endogenous proteins in cultured cells. Star Protocols. 2: 101000. PMID 34917979 DOI: 10.1016/j.xpro.2021.101000 |
0.352 |
|
| 2021 |
Woodley CM, Romer AS, Wang J, Guarnaccia AD, Elion DL, Maxwell JN, Guerrazzi K, McCann TS, Popay TM, Matlock BK, Flaherty DK, Lorey SL, Liu Q, Tansey WP, Weissmiller AM. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler. Oncogene. PMID 33931740 DOI: 10.1038/s41388-021-01804-7 |
0.447 |
|
| 2021 |
Wolpaw AJ, Bayliss R, Büchel G, Dang CV, Eilers M, Gustafson WC, Hansen GM, Jura N, Knapp S, Lemmon MA, Levens D, Maris JM, Marmorstein R, Metallo SJ, Park JR, ... ... Tansey WP, et al. Drugging the 'undruggable' MYCN oncogenic transcription factor: Overcoming previous obstacles to impact childhood cancers. Cancer Research. PMID 33509943 DOI: 10.1158/0008-5472.CAN-20-3108 |
0.403 |
|
| 2021 |
Popay TM, Wang J, Adams CM, Howard GC, Codreanu SG, Sherrod SD, McLean JA, Thomas LR, Lorey SL, Machida YJ, Weissmiller AM, Eischen CM, Liu Q, Tansey WP. MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor-1. Elife. 10. PMID 33416496 DOI: 10.7554/eLife.60191 |
0.409 |
|
| 2020 |
Chacon Simon S, Wang F, Thomas LR, Phan J, Zhao B, Olejniczak ET, Macdonald JD, Shaw JG, Schlund C, Payne WG, Creighton J, Stauffer S, Waterson AG, Tansey WP, Fesik SW. Discovery of WD Repeat-Containing Protein 5 (WDR5)-MYC inhibitors using fragment-based methods and structure-based design. Journal of Medicinal Chemistry. PMID 32223236 DOI: 10.1021/Acs.Jmedchem.0C00224 |
0.425 |
|
| 2020 |
Thomas LR, Adams CM, Fesik SW, Eischen CM, Tansey WP. Targeting MYC through WDR5. Molecular & Cellular Oncology. 7: 1709388. PMID 32158922 DOI: 10.1080/23723556.2019.1709388 |
0.476 |
|
| 2020 |
Bryan AF, Wang J, Howard GC, Guarnaccia AD, Woodley CM, Aho ER, Rellinger EJ, Matlock BK, Flaherty DK, Lorey SL, Chung DH, Fesik SW, Liu Q, Weissmiller AM, Tansey WP. WDR5 is a conserved regulator of protein synthesis gene expression. Nucleic Acids Research. PMID 31996893 DOI: 10.1093/Nar/Gkaa051 |
0.474 |
|
| 2019 |
Tian J, Teuscher K, Aho ER, Alvarado JR, Mills JJ, Meyers KM, Gogliotti RD, Han C, Macdonald JD, Sai J, Shaw JG, Sensintaffar JL, Zhao B, Rietz TA, Thomas LR, ... ... Tansey WP, et al. Discovery and Structure-Based Optimization of Potent and Selective WD repeat domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core. Journal of Medicinal Chemistry. PMID 31858797 DOI: 10.1021/Acs.Jmedchem.9B01608 |
0.429 |
|
| 2019 |
Thomas LR, Adams CM, Wang J, Weissmiller AM, Creighton J, Lorey SL, Liu Q, Fesik SW, Eischen CM, Tansey WP. Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance. Proceedings of the National Academy of Sciences of the United States of America. PMID 31767764 DOI: 10.1073/Pnas.1910391116 |
0.535 |
|
| 2019 |
Macdonald JD, Chacon Simon S, Han C, Wang F, Shaw JG, Howes JE, Sai J, Yuh J, Camper DV, Alicie BM, Alvarado J, Nikhar S, Payne WG, Aho ER, Bauer J, ... ... Tansey WP, et al. Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Protein-Protein Interaction. Journal of Medicinal Chemistry. PMID 31724864 DOI: 10.1021/Acs.Jmedchem.9B01411 |
0.429 |
|
| 2019 |
Weissmiller AM, Wang J, Lorey SL, Howard GC, Martinez E, Liu Q, Tansey WP. Inhibition of MYC by the SMARCB1 tumor suppressor. Nature Communications. 10: 2014. PMID 31043611 DOI: 10.1038/S41467-019-10022-5 |
0.549 |
|
| 2019 |
Aho ER, Wang J, Gogliotti RD, Howard GC, Phan J, Acharya P, Macdonald JD, Cheng K, Lorey SL, Lu B, Wenzel S, Foshage AM, Alvarado J, Wang F, Shaw JG, ... ... Tansey WP, et al. Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity. Cell Reports. 26: 2916-2928.e13. PMID 30865883 DOI: 10.1016/J.Celrep.2019.02.047 |
0.368 |
|
| 2019 |
Popay TM, Thomas LR, Wang J, Liu Q, Tansey WP. Abstract 2600: Interaction of host cell factor-1 with the oncoprotein transcription factor MYC Cancer Research. 79: 2600-2600. DOI: 10.1158/1538-7445.Sabcs18-2600 |
0.559 |
|
| 2018 |
Wang F, Jeon KO, Salovich JM, Macdonald JD, Alvarado J, Gogliotti RD, Phan J, Olejniczak ET, Sun Q, Wang S, Camper DV, Yuh JP, Shaw JG, Sai J, Rossanese OW, ... Tansey WP, et al. Discovery of Potent 2-Aryl-6,7-Dihydro-5 H-Pyrrolo[1,2- a]imidazoles as WDR5 WIN-site Inhibitors Using Fragment-Based Methods and Structure-Based Design. Journal of Medicinal Chemistry. PMID 29889518 DOI: 10.1021/Acs.Jmedchem.8B00375 |
0.309 |
|
| 2018 |
Ng VH, Hang BI, Sawyer LM, Neitzel LR, Crispi EE, Rose KL, Popay TM, Zhong A, Lee LA, Tansey WP, Huppert S, Lee E. Phosphorylation of XIAP at threonine 180 controls its activity in Wnt signaling. Journal of Cell Science. PMID 29678905 DOI: 10.1242/Jcs.210575 |
0.392 |
|
| 2018 |
Guarnaccia AD, Tansey WP. Moonlighting with WDR5: A Cellular Multitasker. Journal of Clinical Medicine. 7. PMID 29385767 DOI: 10.3390/Jcm7020021 |
0.403 |
|
| 2018 |
Guarnaccia AD, Tansey WP. Abstract 972: Defining the molecular context of MYC and WDR5 at chromatin Cancer Research. 78: 972-972. DOI: 10.1158/1538-7445.Am2018-972 |
0.557 |
|
| 2017 |
Parang B, Kaz AM, Barrett CW, Short SP, Ning W, Keating CE, Mittal MK, Naik RD, Washington MK, Revetta FL, Smith JJ, Chen X, Wilson KT, Brand T, Bader DM, ... Tansey WP, et al. BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis. Gut. 66: 852-862. PMID 28389570 DOI: 10.1136/Gutjnl-2015-310255 |
0.419 |
|
| 2017 |
Tansey W. Abstract IA15: Novel approaches for targeting MYC Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Pmccavuln16-Ia15 |
0.519 |
|
| 2017 |
Foshage AM, Thomas LR, Stauffer SR, Fesik SW, Tansey WP. Abstract PR09: Targeting the MYC-WDR5 nexus in colorectal cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Crc16-Pr09 |
0.306 |
|
| 2017 |
Guarnaccia AD, Weissmiller AM, Thomas LR, Tansey WP. Abstract 4994: Understanding the MYC and WDR5 interaction at chromatin Cancer Research. 77: 4994-4994. DOI: 10.1158/1538-7445.Am2017-4994 |
0.364 |
|
| 2016 |
Howard GC, Tansey WP. Interaction of Gcn4 with target gene chromatin is modulated by proteasome function. Molecular Biology of the Cell. PMID 27385344 DOI: 10.1091/Mbc.E16-03-0192 |
0.517 |
|
| 2016 |
McCann TS, Guo Y, McDonald WH, Tansey WP. Antagonistic roles for the ubiquitin ligase Asr1 and the ubiquitin-specific protease Ubp3 in subtelomeric gene silencing. Proceedings of the National Academy of Sciences of the United States of America. PMID 26787877 DOI: 10.1073/Pnas.1518375113 |
0.47 |
|
| 2015 |
Chakraborty AA, Tansey WP. Do changes in the c-MYC coding sequence contribute to tumorigenesis? Molecular & Cellular Oncology. 2: e965631. PMID 27308414 DOI: 10.4161/23723548.2014.965631 |
0.656 |
|
| 2015 |
Thomas LR, Foshage AM, Weissmiller AM, Popay TM, Grieb BC, Qualls SJ, Ng V, Carboneau B, Lorey S, Eischen CM, Tansey WP. Interaction of MYC with host cell factor-1 is mediated by the evolutionarily conserved Myc box IV motif. Oncogene. PMID 26522729 DOI: 10.1038/Onc.2015.416 |
0.569 |
|
| 2015 |
Thomas LR, Foshage AM, Weissmiller AM, Tansey WP. The MYC-WDR5 Nexus and Cancer. Cancer Research. 75: 4012-5. PMID 26383167 DOI: 10.1158/0008-5472.Can-15-1216 |
0.562 |
|
| 2015 |
Thomas LR, Wang Q, Grieb BC, Phan J, Foshage AM, Sun Q, Olejniczak ET, Clark T, Dey S, Lorey S, Alicie B, Howard GC, Cawthon B, Ess KC, Eischen CM, ... ... Tansey WP, et al. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. Molecular Cell. 58: 440-52. PMID 25818646 DOI: 10.2210/Pdb6Dak/Pdb |
0.523 |
|
| 2015 |
Chakraborty AA, Scuoppo C, Dey S, Thomas LR, Lorey SL, Lowe SW, Tansey WP. A common functional consequence of tumor-derived mutations within c-MYC. Oncogene. 34: 2406-9. PMID 24998853 DOI: 10.1038/Onc.2014.186 |
0.698 |
|
| 2015 |
Thomas LR, Tansey WP. MYC and Chromatin The Open Access Journal of Science and Technology. 3. DOI: 10.11131/2015/101124 |
0.551 |
|
| 2014 |
McCann TS, Tansey WP. Functions of the proteasome on chromatin. Biomolecules. 4: 1026-44. PMID 25422899 DOI: 10.3390/biom4041026 |
0.347 |
|
| 2014 |
Bonizec M, Hérissant L, Pokrzywa W, Geng F, Wenzel S, Howard GC, Rodriguez P, Krause S, Tansey WP, Hoppe T, Dargemont C. The ubiquitin-selective chaperone Cdc48/p97 associates with Ubx3 to modulate monoubiquitylation of histone H2B. Nucleic Acids Research. 42: 10975-86. PMID 25183520 DOI: 10.1093/Nar/Gku786 |
0.481 |
|
| 2014 |
Galligan JJ, Rose KL, Beavers WN, Hill S, Tallman KA, Tansey WP, Marnett LJ. Stable histone adduction by 4-oxo-2-nonenal: a potential link between oxidative stress and epigenetics. Journal of the American Chemical Society. 136: 11864-6. PMID 25099620 DOI: 10.1021/Ja503604T |
0.32 |
|
| 2014 |
Tansey WP. Mammalian MYC Proteins and Cancer New Journal of Science. 2014: 1-27. DOI: 10.1155/2014/757534 |
0.501 |
|
| 2012 |
Geng F, Tansey WP. Similar temporal and spatial recruitment of native 19S and 20S proteasome subunits to transcriptionally active chromatin. Proceedings of the National Academy of Sciences of the United States of America. 109: 6060-5. PMID 22474342 DOI: 10.1073/Pnas.1200854109 |
0.433 |
|
| 2012 |
Geng F, Wenzel S, Tansey WP. Ubiquitin and proteasomes in transcription. Annual Review of Biochemistry. 81: 177-201. PMID 22404630 DOI: 10.1146/Annurev-Biochem-052110-120012 |
0.506 |
|
| 2012 |
Simpson D, Muthuswamy S, Tansey WP. Impact of Epithelial Organization on Myc Expression and Activity--Response Cancer Research. 72: 1036-1036. DOI: 10.1158/0008-5472.Can-11-3509 |
0.356 |
|
| 2012 |
Tansey WP. An MBoC Favorite: Proteasomal proteomics: identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes Molecular Biology of the Cell. 23: 1606-1606. DOI: 10.1091/Mbc.E12-02-0148 |
0.375 |
|
| 2011 |
Thomas LR, Tansey WP. Proteolytic control of the oncoprotein transcription factor Myc. Advances in Cancer Research. 110: 77-106. PMID 21704229 DOI: 10.1016/B978-0-12-386469-7.00004-9 |
0.593 |
|
| 2011 |
Leung A, Cajigas I, Jia P, Ezhkova E, Brickner JH, Zhao Z, Geng F, Tansey WP. Histone H2B ubiquitylation and H3 lysine 4 methylation prevent ectopic silencing of euchromatic loci important for the cellular response to heat. Molecular Biology of the Cell. 22: 2741-53. PMID 21680712 DOI: 10.1091/Mbc.E11-05-0426 |
0.413 |
|
| 2011 |
Simpson DR, Yu M, Zheng S, Zhao Z, Muthuswamy SK, Tansey WP. Epithelial cell organization suppresses Myc function by attenuating Myc expression. Cancer Research. 71: 3822-30. PMID 21610111 DOI: 10.1158/0008-5472.Can-10-3782 |
0.43 |
|
| 2011 |
Lee SB, Kim JJ, Chung JS, Lee MS, Lee KH, Kim BS, Tansey WP, Do Yoo Y. Romo1 is a negative-feedback regulator of Myc. Journal of Cell Science. 124: 1911-24. PMID 21558421 DOI: 10.1242/jcs.079996 |
0.344 |
|
| 2010 |
Collins GA, Gomez TA, Deshaies RJ, Tansey WP. Combined chemical and genetic approach to inhibit proteolysis by the proteasome. Yeast (Chichester, England). 27: 965-74. PMID 20625982 DOI: 10.1002/Yea.1805 |
0.427 |
|
| 2010 |
Wang X, Muratani M, Tansey WP, Ptashne M. Proteolytic instability and the action of nonclassical transcriptional activators. Current Biology : Cb. 20: 868-71. PMID 20417106 DOI: 10.1016/J.Cub.2010.03.029 |
0.428 |
|
| 2009 |
Collins GA, Lipford JR, Deshaies RJ, Tansey WP. Gal4 turnover and transcription activation. Nature. 461: E7; discussion E8. PMID 19812621 DOI: 10.1038/Nature08406 |
0.4 |
|
| 2009 |
Chakraborty AA, Tansey WP. Inference of cell cycle-dependent proteolysis by laser scanning cytometry. Experimental Cell Research. 315: 1772-8. PMID 19331831 DOI: 10.1016/J.Yexcr.2009.01.011 |
0.689 |
|
| 2009 |
Daulny A, Tansey WP. Damage control: DNA repair, transcription, and the ubiquitin-proteasome system. Dna Repair. 8: 444-8. PMID 19272841 DOI: 10.1016/J.Dnarep.2009.01.017 |
0.333 |
|
| 2009 |
Chakraborty AA, Tansey WP. Adenoviral E1A function through Myc. Cancer Research. 69: 6-9. PMID 19117980 DOI: 10.1158/0008-5472.Can-08-3026 |
0.76 |
|
| 2008 |
Daulny A, Geng F, Muratani M, Geisinger JM, Salghetti SE, Tansey WP. Modulation of RNA polymerase II subunit composition by ubiquitylation. Proceedings of the National Academy of Sciences of the United States of America. 105: 19649-54. PMID 19064926 DOI: 10.1073/Pnas.0809372105 |
0.447 |
|
| 2008 |
Geng F, Tansey WP. Polyubiquitylation of histone H2B. Molecular Biology of the Cell. 19: 3616-24. PMID 18562693 DOI: 10.1091/Mbc.E08-01-0050 |
0.351 |
|
| 2008 |
Kurland JF, Tansey WP. Myc-mediated transcriptional repression by recruitment of histone deacetylase. Cancer Research. 68: 3624-9. PMID 18483244 DOI: 10.1158/0008-5472.Can-07-6552 |
0.547 |
|
| 2008 |
Tworkowski KA, Chakraborty AA, Samuelson AV, Seger YR, Narita M, Hannon GJ, Lowe SW, Tansey WP. Adenovirus E1A targets p400 to induce the cellular oncoprotein Myc Proceedings of the National Academy of Sciences of the United States of America. 105: 6103-6108. PMID 18413597 DOI: 10.1073/Pnas.0802095105 |
0.723 |
|
| 2007 |
Tansey WP. Denaturing protein immunoprecipitation from yeast. Csh Protocols. 2007: pdb.prot4643. PMID 21356925 DOI: 10.1101/Pdb.Prot4643 |
0.343 |
|
| 2007 |
Tansey WP. Yeast Chromatin Immunoprecipitation (ChIP) Assay. Csh Protocols. 2007: pdb.prot4642. PMID 21356924 DOI: 10.1101/Pdb.Prot4642 |
0.374 |
|
| 2007 |
Tansey WP. Pulse-chase assay for measuring protein stability in yeast. Csh Protocols. 2007: pdb.prot4641. PMID 21356923 DOI: 10.1101/Pdb.Prot4641 |
0.382 |
|
| 2007 |
Tansey WP. Denaturing protein immunoprecipitation from Mammalian cells. Csh Protocols. 2007: pdb.prot4619. PMID 21356921 DOI: 10.1101/Pdb.Prot4619 |
0.357 |
|
| 2007 |
Pal B, Chan NC, Helfenbaum L, Tan K, Tansey WP, Gething MJ. SCFCdc4-mediated degradation of the Hac1p transcription factor regulates the unfolded protein response in Saccharomyces cerevisiae. Molecular Biology of the Cell. 18: 426-40. PMID 17108329 DOI: 10.1091/Mbc.E06-04-0304 |
0.504 |
|
| 2006 |
Tansey WP. Detection of ubiquitylated proteins in mammalian cells. Csh Protocols. 2006. PMID 22485991 DOI: 10.1101/Pdb.Prot4616 |
0.388 |
|
| 2006 |
Tansey WP. Detection of ubiquitylated proteins in yeast. Csh Protocols. 2006. PMID 22484671 DOI: 10.1101/Pdb.Prot4615 |
0.391 |
|
| 2006 |
Tansey WP. Freeze-thaw lysis for extraction of proteins from Mammalian cells. Csh Protocols. 2006. PMID 22484670 DOI: 10.1101/Pdb.Prot4614 |
0.327 |
|
| 2006 |
Tansey WP. 6-azauracil sensitivity assay for yeast. Csh Protocols. 2006. PMID 22484669 DOI: 10.1101/Pdb.Prot4613 |
0.356 |
|
| 2006 |
Collins GA, Tansey WP. The proteasome: a utility tool for transcription? Current Opinion in Genetics & Development. 16: 197-202. PMID 16503126 DOI: 10.1016/J.Gde.2006.02.009 |
0.506 |
|
| 2006 |
Ezhkova E, Tansey WP. Chromatin immunoprecipitation to study protein-DNA interactions in budding yeast. Methods in Molecular Biology (Clifton, N.J.). 313: 225-44. PMID 16118437 DOI: 10.1385/1-59259-958-3:225 |
0.37 |
|
| 2005 |
Lee D, Ezhkova E, Li B, Pattenden SG, Tansey WP, Workman JL. The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. Cell. 123: 423-36. PMID 16269334 DOI: 10.1016/J.Cell.2005.08.015 |
0.482 |
|
| 2005 |
Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature. 436: 807-11. PMID 16094360 DOI: 10.1038/Nature03845 |
0.479 |
|
| 2005 |
Muratani M, Kung C, Shokat KM, Tansey WP. The F box protein Dsg1/Mdm30 is a transcriptional coactivator that stimulates Gal4 turnover and cotranscriptional mRNA processing. Cell. 120: 887-99. PMID 15797387 DOI: 10.1016/J.Cell.2004.12.025 |
0.442 |
|
| 2005 |
Herbst A, Hemann MT, Tworkowski KA, Salghetti SE, Lowe SW, Tansey WP. A conserved element in Myc that negatively regulates its proapoptotic activity. Embo Reports. 6: 177-83. PMID 15678160 DOI: 10.1038/Sj.Embor.7400333 |
0.764 |
|
| 2004 |
Baumeister W, Bachmair A, Chau V, Cohen R, Coffino P, Demartino G, Deshaies R, Dohmen J, Emr S, Finley D, Hampton R, Hill C, Hochstrasser M, Huber R, Jackson P, ... ... Tansey W, et al. Varshavsky's contributions. Science (New York, N.Y.). 306: 1290-2. PMID 15550643 DOI: 10.1126/Science.306.5700.1290 |
0.361 |
|
| 2004 |
Kurland JF, Tansey WP. Crashing waves of destruction: the cell cycle and APC(Cdh1) regulation of SCF(Skp2). Cancer Cell. 5: 305-6. PMID 15093536 DOI: 10.1016/S1535-6108(04)00091-1 |
0.378 |
|
| 2004 |
Tubon TC, Tansey WP, Herr W. A nonconserved surface of the TFIIB zinc ribbon domain plays a direct role in RNA polymerase II recruitment. Molecular and Cellular Biology. 24: 2863-74. PMID 15024075 DOI: 10.1128/Mcb.24.7.2863-2874.2004 |
0.363 |
|
| 2004 |
Herbst A, Salghetti SE, Kim SY, Tansey WP. Multiple cell-type-specific elements regulate Myc protein stability. Oncogene. 23: 3863-71. PMID 15021906 DOI: 10.1038/Sj.Onc.1207492 |
0.51 |
|
| 2004 |
Janicki SM, Tsukamoto T, Salghetti SE, Tansey WP, Sachidanandam R, Prasanth KV, Ried T, Shav-Tal Y, Bertrand E, Singer RH, Spector DL. From silencing to gene expression: real-time analysis in single cells. Cell. 116: 683-98. PMID 15006351 DOI: 10.1016/S0092-8674(04)00171-0 |
0.449 |
|
| 2004 |
Ezhkova E, Tansey WP. Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3. Molecular Cell. 13: 435-42. PMID 14967150 DOI: 10.1016/S1097-2765(04)00026-7 |
0.32 |
|
| 2004 |
Herbst A, Salghetti SE, Kim SY, Tansey WP. Erratum: Multiple cell-type-specific elements regulate Myc protein stability Oncogene. 23: 9448-9448. DOI: 10.1038/Sj.Onc.1208362 |
0.367 |
|
| 2003 |
Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP. Skp2 regulates Myc protein stability and activity. Molecular Cell. 11: 1177-88. PMID 12769843 DOI: 10.1016/S1097-2765(03)00173-4 |
0.775 |
|
| 2003 |
Muratani M, Tansey WP. How the ubiquitin-proteasome system controls transcription. Nature Reviews. Molecular Cell Biology. 4: 192-201. PMID 12612638 DOI: 10.1038/Nrm1049 |
0.451 |
|
| 2002 |
Tworkowski KA, Salghetti SE, Tansey WP. Stable and unstable pools of Myc protein exist in human cells. Oncogene. 21: 8515-20. PMID 12466972 DOI: 10.1038/Sj.Onc.1205976 |
0.761 |
|
| 2002 |
Alarcon-Vargas D, Tansey WP, Ronai Z. Regulation of c-myc stability by selective stress conditions and by MEKK1 requires aa 127-189 of c-myc. Oncogene. 21: 4384-91. PMID 12080469 DOI: 10.1038/Sj.Onc.1205543 |
0.402 |
|
| 2002 |
Méndez J, Zou-Yang XH, Kim SY, Hidaka M, Tansey WP, Stillman B. Human origin recognition complex large subunit is degraded by ubiquitin-mediated proteolysis after initiation of DNA replication. Molecular Cell. 9: 481-91. PMID 11931757 DOI: 10.1016/S1097-2765(02)00467-7 |
0.399 |
|
| 2002 |
Ejkova E, Tansey WP. Old dogs and new tricks: meeting on mechanisms of eukaryotic transcription. Embo Reports. 3: 219-23. PMID 11882540 DOI: 10.1093/Embo-Reports/Kvf054 |
0.365 |
|
| 2001 |
Salghetti SE, Caudy AA, Chenoweth JG, Tansey WP. Regulation of transcriptional activation domain function by ubiquitin. Science (New York, N.Y.). 293: 1651-3. PMID 11463878 DOI: 10.1126/Science.1062079 |
0.49 |
|
| 2001 |
Herbst A, Tansey WP. HAM: a new epitope-tag for in vivo protein labeling. Molecular Biology Reports. 27: 203-8. PMID 11455955 DOI: 10.1023/A:1011008018565 |
0.399 |
|
| 2001 |
Tansey WP. Transcriptional activation: risky business. Genes & Development. 15: 1045-50. PMID 11331599 DOI: 10.1101/Gad.896501 |
0.486 |
|
| 2000 |
Tansey WP. Transcriptional regulation: RUPture in the ER. Nature Cell Biology. 2: E175-7. PMID 11025674 DOI: 10.1038/35036420 |
0.487 |
|
| 2000 |
Salghetti SE, Muratani M, Wijnen H, Futcher B, Tansey WP. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proceedings of the National Academy of Sciences of the United States of America. 97: 3118-23. PMID 10706616 DOI: 10.1073/Pnas.97.7.3118 |
0.53 |
|
| 1999 |
Salghetti SE, Kim SY, Tansey WP. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. The Embo Journal. 18: 717-26. PMID 9927431 DOI: 10.1093/Emboj/18.3.717 |
0.586 |
|
| 1999 |
Tansey WP. How Cells Use Proteolysis to Control Their Growth Molecular Medicine. 5: 773-782. DOI: 10.1007/Bf03401990 |
0.441 |
|
| 1997 |
Tansey WP, Herr W. TAFs: guilt by association? Cell. 88: 729-32. PMID 9118213 DOI: 10.1016/S0092-8674(00)81916-9 |
0.49 |
|
| 1997 |
Tansey WP, Herr W. Selective use of TBP and TFIIB revealed by a TATA-TBP-TFIIB array with altered specificity. Science (New York, N.Y.). 275: 829-31. PMID 9012349 DOI: 10.1126/Science.275.5301.829 |
0.48 |
|
| 1996 |
Pendergrast PS, Morrison D, Tansey WP, Hernandez N. Mutations in the carboxy-terminal domain of TBP affect the synthesis of human immunodeficiency virus type 1 full-length and short transcripts similarly. Journal of Virology. 70: 5025-34. PMID 8764009 DOI: 10.1128/Jvi.70.8.5025-5034.1996 |
0.468 |
|
| 1995 |
Tansey WP, Herr W. The ability to associate with activation domains in vitro is not required for the TATA box-binding protein to support activated transcription in vivo. Proceedings of the National Academy of Sciences of the United States of America. 92: 10550-4. PMID 7479838 DOI: 10.1073/Pnas.92.23.10550 |
0.486 |
|
| 1994 |
Tansey WP, Ruppert S, Tjian R, Herr W. Multiple regions of TBP participate in the response to transcriptional activators in vivo Genes and Development. 8: 2756-2769. PMID 7958931 DOI: 10.1101/Gad.8.22.2756 |
0.49 |
|
| Show low-probability matches. |